David Darling
Non-Executive Director
David Darling is a highly credentialed leader and executive who brings a wealth of commercial experience to BCAL from his prior role as CEO of Pacific Edge, a NZX50 and ASX listed business focused on commercialising its bladder cancer diagnostics tests across global markets, with commercial operations in New Zealand, Australia, Singapore and the USA. Prior to Pacific Edge, Mr Darling held senior management positions with Fletcher Challenge.
Mr Darling has a background as a scientist with a specialty in genetics and has more than three decades of experience in developing and commercialising life sciences and biotechnology products.
Meet the rest of the team
BCAL is led by a team of experts with deep experience in biotechnology, diagnostics, and healthcare innovation. Our leadership is dedicated to advancing scientific excellence and bringing practical, life-changing solutions to women worldwide.
Shane Ryan
Chief Executive Officer
Kathy Koskiris
Director of Clinical Laboratory Services
Guy Robertson
Chief Financial Officer & Company Secretary
Dr Simon Preston
Director Clinical Research
Alexandra Feetham
Head of Innovation
Kim Kirkham
National Clinical Program Director
Dr Mark David
Director Discovery of Product Development. Senior Clinical Scientist
Dr Klaus-Peter Adam
Director of US Research & Product